Oppenheimer & Co’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,675
Closed -$327K 1471
2021
Q4
$327K Buy
2,675
+334
+14% +$37.1K 0.01% 1190
2021
Q3
$269K Buy
+2,341
New +$248K 0.01% 1267
2016
Q4
Sell
-12,107
Closed -$386K 1281
2016
Q3
$386K Sell
12,107
-71,632
-86% -$2.72M 0.01% 905
2016
Q2
$3.35M Buy
+83,739
New +$3.1M 0.1% 240

Other funds holding AMN

Oppenheimer & Co's AMN Position: Q1 2022 in Review

Oppenheimer & Co sold out of AMN Healthcare (AMN) in Q1 2022, closing a stake of 2,675 shares — an estimated $327K sold.

Oppenheimer & Co first reported a position in AMN in Q2 2016 and held it in 4 quarters. The position peaked at $3.35M in Q2 2016. 416 funds tracked by Wall St. Rank hold AMN as of Q1 2022.

  • Oppenheimer & Co reported no remaining AMN Healthcare position as of Q1 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 2,675 AMN Healthcare shares in Q1 2022, an estimated $327K.
  • Oppenheimer & Co first reported a position in AMN Healthcare in Q2 2016 and held it in 4 quarters.
  • Oppenheimer & Co's AMN Healthcare position peaked at $3.35M in Q2 2016.
  • 416 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2022.

Based on Oppenheimer & Co's 13F filing for Q1 2022, filed 12 May 2022.